Staking Will Define Bitcoin's Role in the Global Digital Economy in 2025
As a significant third native use case for bitcoin, staking will increase bitcoin’s impact on the world's stage.
Investors' allocation to US stocks hits record high amid 'super-bullish sentiment': BofA survey
Increased optimism about growth in the US economy and new policies from the Trump administration have investors growing increasingly bullish on US stocks heading into 2025.
Nvidia stock slumps into a correction and Broadcom sinks despite its 'Nvidia moment'
Nvidia (NVDA) stock is in correction territory, and rival chipmaker Broadcom’s (AVGO) late-year boost took a hit Tuesday morning.
Viridian Therapeutics sees stock soar after Phase III TED success
The company’s chronic thyroid eye disease treatment, veligrotug, was able to reduce eye bulge by 56% compared with placebo.
MicroStrategy breaks into Nasdaq 100, amplifying Bitcoin’s reach
Massive Bitcoin holdings secure a top exchange position, linking prominent funds to digital currency exposure.
Crypto and Rates to Drive US Convertible Debt Growth in 2025
(Bloomberg) -- The US convertible securities market could test its pandemic-era highs in 2025, bankers say, with interest rates remaining above where many on Wall Street expected and a crypto asset-related strategy that shows no sign of going away soon.Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearEquity-linked securities issued by American companies reached $81 billion i
Pfizer Stock Rises as 2025 Outlook in Line With Expectations
Pfizer shares rose Tuesday morning after the pharmaceutical company affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.
Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?
On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-111 study of icovamenib in patients with type 2 diabetes (T2D). Icovamenib was investigated in three different dosing arms with a primary follow-up after 26 weeks: Arm A at 100mg QD (once daily) for 8 weeks, Arm B at 100mg QD for 12 weeks, and Arm C at 100 mg QD for 8 weeks and 100mg BID (twice daily) for 4 weeks. Also Read: FDA Removes Clinical Hold On Biomea Fusion’s Early-Stage Trials For Potential
Ripple’s RLUSD stablecoin makes debut on crypto exchanges
RLUSD is initially available on exchanges including Uphold, Bitso, MoonPay, Archax, and CoinMENA.
November retail sales top Wall Street's expectations
Retail sales increased in November amid a strong start to the holiday shopping season.
Popular Post
- Powell says Fed will likely cut rates cautiously given persistent inflation pressures Nov 14, 2024
- S&P 500 Gains and Losses Today: Hershey Stock Simmers as Mondelez Weighs Takeover Dec 09, 2024
- Bitcoin Trading Volume Surged to $2.8T in January to August Period Sep 10, 2024
- Nvidia is flashing a sell signal and its huge rally marks the peak of a 40-year market cycle, veteran strategist says Sep 03, 2024
- Prosecutors Tell NY Court They Didn’t Renege on FTX Exec Ryan Salame’s Plea Deal Sep 06, 2024
- MEV Has Spread to Bitcoin, in Subtler Forms Than on Ethereum Jul 09, 2024
- Trump's economic agenda for his second term is clouding the outlook for mortgage rates Nov 13, 2024
- S&P 500 Earnings Hinge on Trump, Harris Tax Plans, Goldman Says Sep 05, 2024
- Atlanta Fed's Bostic violated trading rules, US central bank watchdog says Sep 11, 2024
- Fed's Logan calls for 'gradual' rate cuts, says 'should not rush' Oct 09, 2024